<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">7804028</journal-id><journal-id journal-id-type="pubmed-jr-id">372</journal-id><journal-id journal-id-type="nlm-ta">Allergy</journal-id><journal-id journal-id-type="iso-abbrev">Allergy</journal-id><journal-title-group><journal-title>Allergy</journal-title></journal-title-group><issn pub-type="ppub">0105-4538</issn><issn pub-type="epub">1398-9995</issn></journal-meta><article-meta><article-id pub-id-type="pmid">37408337</article-id><article-id pub-id-type="pmc">PMC10732592</article-id><article-id pub-id-type="doi">10.1111/all.15809</article-id><article-id pub-id-type="manuscript">NIHMS1945919</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>D-2-hydroxyglutarate suppresses allergic sensitization in a murine model of experimental asthma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tharakan</surname><given-names>Anuj</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Ankit</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Allegood</surname><given-names>Jeremy</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Cowart</surname><given-names>Lauren Ashley</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4791-2694</contrib-id><name><surname>Conrad</surname><given-names>Daniel H.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9948-5463</contrib-id><name><surname>Martin</surname><given-names>Rebecca K.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA</aff><aff id="A2"><label>2</label>Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia, USA</aff><aff id="A3"><label>3</label>Hunter Holmes McGuire Veteran&#x02019;s Affairs Medical Center, Richmond, Virginia, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">AUTHOR CONTRIBUTIONS</p><p id="P2">A.T. and R.K.M. made substantial contributions to concept and design. A.T., A.K., J.A., and R.K.M. made substantial contributions to analysis and/or interpretation of data. All authors were involved in drafting and/or critically revising the manuscript.</p></fn><corresp id="CR1"><bold>Correspondence</bold> Rebecca K. Martin, Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA. <email>rebecca.martin@vcuhealth.org</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>05</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>12</month><year>2023</year></pub-date><volume>78</volume><issue>11</issue><fpage>3014</fpage><lpage>3016</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions></article-meta></front><body><sec id="S1"><title>To the Editor,</title><p id="P3">Asthma is a chronic inflammatory disease affecting the airways which is characterized by reversible airflow obstruction, bronchial hyperresponsiveness, and airway remodeling. In allergic asthma, this airway pathology is mediated by Type 2 cytokines (IL-4, IL-5, and IL-13) and allergen-specific IgE. IL-4, IL-5, and IL-13 are predominantly produced by lung resident T helper 2 (Th2) cells and Type 2 innate lymphoid cells. The production of allergen-specific IgE from B cells is driven by a subset of IL-4 and IL-13 producing T follicular helper cells termed T follicular helper 13 (Tfh13) cells.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> The initiation of these T-cell responses is mediated by dendritic cells (DCs). The mechanisms by which DCs regulate Th2 and Tfh13 polarization, however, are unclear. Several genome-wide association studies have identified that single-nucleotide polymorphisms (SNPs) in the <italic toggle="yes">D2HGDH</italic> locus are associated with allergic asthma and allergic rhinitis risk, with the G allele of rs34290285 associated with a lower risk of disease.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The <italic toggle="yes">D2HGDH</italic> gene encodes the enzyme D-2-hydroxyglutarate dehydrogenase (D2HGDH), which converts D-2-hydroxyglutarate (D2HG) to &#x003b1;-ketoglutarate (&#x003b1;-KG).</p><p id="P4">To elucidate the functional consequences of these SNPs, the regulatory landscape of the <italic toggle="yes">D2HGDH</italic> locus was analyzed using the ENCODE database. We found that the sentinel SNP, rs34290285, resides within a candidate cis-regulatory element (cCRE) with distal enhancer-like features in human monocytes (<xref rid="F1" ref-type="fig">Figure 1A</xref>). Previously described lung eQTL analysis of the 10 most significant SNPs revealed that these asthma risk alleles are associated with reduced expression of <italic toggle="yes">D2HGDH</italic> mRNA in the lung (<xref rid="F1" ref-type="fig">Figure 1B</xref>).<sup><xref rid="R3" ref-type="bibr">3</xref></sup> As the lead SNP, rs34290285 is also associated with <italic toggle="yes">GAL3ST2</italic>, the effects of <italic toggle="yes">GAL3ST2</italic> cannot be excluded.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The downregulation of <italic toggle="yes">D2HGDH</italic> expression suggests that these SNPs may promote accumulation of D2HG, which is a potent endogenous inhibitor of &#x003b1;-KG-dependent dioxygenases, a group of histone demethylase and prolyl hydroxylase enzymes.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Recent studies demonstrate that inhibition of these &#x003b1;-KG dependent histone demethylases in DCs results in a tolerogenic DC phenotype.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> D-2HG and &#x003b1;-KG, therefore, reciprocally regulate these dioxygenase enzymes to dynamically regulate gene expression via epigenetic mechanisms. Thus, we performed metabolomic analysis of murine bone marrow-derived dendritic cells following stimulation with LPS or the allergen <italic toggle="yes">Alternaria</italic> which revealed a significant increase in the ratio of &#x003b1;-KG to hydroxyglutarate following <italic toggle="yes">Alternaria</italic> treatment (<xref rid="F1" ref-type="fig">Figure 1C</xref>).</p><p id="P5">Therefore, we predicted that D-2HG may modulate DC function to alter allergic sensitization in a murine model of allergic airway inflammation. We found that intranasal administration of octyl-D-2HG, a cell permeable form of D-2HG, prior to intranasal exposure to <italic toggle="yes">Alternaria</italic> significantly reduced mediastinal lymph node (mLN) Th2, Tfh13, and Tfh2 cell polarization, but overall Tfh priming was unimpaired (<xref rid="F2" ref-type="fig">Figure 2A</xref>&#x02013;<xref rid="F2" ref-type="fig">D</xref>. <xref rid="SD1" ref-type="supplementary-material">Figure S1A</xref>,<xref rid="SD1" ref-type="supplementary-material">B</xref>). Further, octyl-D2HG impaired mLN IgE<sup>+</sup> germinal center B cell (GCBC) and IgE<sup>+</sup> plasma cell (PC) differentiation (<xref rid="F2" ref-type="fig">Figure 2E</xref>,<xref rid="F2" ref-type="fig">F</xref>). IgG1<sup>+</sup> GCBC and PC differentiation, however, was unaffected by octyl-D2HG administration (<xref rid="SD1" ref-type="supplementary-material">Figure S1C</xref>,<xref rid="SD1" ref-type="supplementary-material">D</xref>). Additionally, octyl-D-2HG administration promoted T follicular regulatory (Tfr) cell polarization, which act to restrain IgE production in allergic asthma (<xref rid="F2" ref-type="fig">Figure 2G</xref>).<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Intranasal treatment of octyl-D2HG in a model of established murine allergic asthma resulted in a durable suppression of airway hyperreactivity for 4 days following treatment (<xref rid="F2" ref-type="fig">Figure 2H</xref>,<xref rid="F2" ref-type="fig">I</xref>) Additionally, mice treated with octyl-D2HG exhibited reduced levels of airway antigen-specific IgE and MCPT-1, indicating suppression of airway mast cell degranulation (<xref rid="F2" ref-type="fig">Figure 2J</xref>,<xref rid="F2" ref-type="fig">K</xref>).</p><p id="P6">Overall, these data demonstrate that D2HG critically regulates allergic sensitization and the polarization of Th2 and Tfh13 cells following allergen exposure. Further, we demonstrate that D-2HG induces Tfr cell differentiation in response to allergens in a murine model of allergic asthma, but it is not clear if this is the mechanism by which D2HG reduces allergic airway inflammation. Octyl-D2HG treatment in allergen-sensitized mice demonstrated significant attenuation of airway hyperreactivity and may therefore be a potential therapeutic approach for the treatment of allergic asthma and other IgE-mediated diseases.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplemental methods and figures</label><media xlink:href="NIHMS1945919-supplement-Supplemental_methods_and_figures.docx" id="d64e265" position="anchor"/></supplementary-material></sec></body><back><ack id="S2"><title>FUNDING INFORMATION</title><p id="P7">This work was supported by funding from VCU&#x02019;s CTSA (UL1TR002649 from the National Center for Advancing Translational Sciences) to R.K.M. and the CCTR Endowment Fund of VCU. Services and products in support of the research project were generated by the Virginia Commonwealth University (VCU) Massey Cancer Center Flow Cytometry Shared Resource and Metabolomics and Lipidomics Shared Resource supported, in part, with funding from NIH-NCI Cancer Support Grant P30 CA016059.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P9">CONFLICT OF INTEREST STATEMENT</p><p id="P10">Rebecca K. Martin and Anuj Tharakan own stock in Pleros Therapeutics Inc. which is currently of no value. The rest of the authors have no conflicts of interest to declare.</p></fn><fn id="FN3"><p id="P11">SUPPORTING INFORMATION</p><p id="P12">Additional supporting information can be found online in the Supporting Information section at the end of this article.</p></fn></fn-group><sec sec-type="data-availability" id="S3"><title>DATA AVAILABILITY STATEMENT</title><p id="P8">The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Kuruvilla</surname><given-names>ME</given-names></name>, <name><surname>Lee</surname><given-names>FE</given-names></name>, <name><surname>Lee</surname><given-names>GB</given-names></name>. <article-title>Understanding asthma phenotypes, Endotypes, and mechanisms of disease</article-title>. <source>Clin Rev Allergy Immunol</source>. <year>2019</year>;<volume>56</volume>:<fpage>219</fpage>&#x02013;<lpage>233</lpage>.<pub-id pub-id-type="pmid">30206782</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Gowthaman</surname><given-names>U</given-names></name>, <name><surname>Chen</surname><given-names>JS</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name>, <etal/>
<article-title>Identification of a T follicular helper cell subset that drives anaphylactic IgE</article-title>. <source>Science</source>. <year>2019</year>;<volume>365</volume>:<fpage>eaaw6433</fpage>.<pub-id pub-id-type="pmid">31371561</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>Z</given-names></name>, <name><surname>Lee</surname><given-names>PH</given-names></name>, <name><surname>Chaffin</surname><given-names>MD</given-names></name>, <etal/>
<article-title>A genome-wide cross-trait analysis from UK biobank highlights the shared genetic architecture of asthma and allergic diseases</article-title>. <source>Nat Genet</source>. <year>2018</year>;<volume>50</volume>:<fpage>857</fpage>&#x02013;<lpage>864</lpage>.<pub-id pub-id-type="pmid">29785011</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Du</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>. <article-title>The roles of 2-Hydroxyglutarate</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<fpage>651317</fpage>.<pub-id pub-id-type="pmid">33842477</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Donas</surname><given-names>C</given-names></name>, <name><surname>Carrasco</surname><given-names>M</given-names></name>, <name><surname>Fritz</surname><given-names>M</given-names></name>, <etal/>
<article-title>The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs</article-title>. <source>J Autoimmun</source>. <year>2016</year>;<volume>75</volume>:<fpage>105</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">27528513</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Clement</surname><given-names>RL</given-names></name>, <name><surname>Daccache</surname><given-names>J</given-names></name>, <name><surname>Mohammed</surname><given-names>MT</given-names></name>, <etal/>
<article-title>Follicular regulatory T cells control humoral and allergic immunity by restraining early B cell responses</article-title>. <source>Nat Immunol</source>. <year>2019</year>;<volume>20</volume>:<fpage>1360</fpage>&#x02013;<lpage>1371</lpage>.<pub-id pub-id-type="pmid">31477921</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>FIGURE 1</label><caption><p id="P13">SNPs in the D2HGDH gene are associated with asthma. (A) Mapping of cCRE regions in the <italic toggle="yes">D2HGDH</italic> gene from ENCODE. Location of the sentinel SNP rs34290285 is noted. (B) Lung eQTL effect size, <italic toggle="yes">p</italic>-values, and minor allele frequencies for the 10 SNPs most strongly associated with asthma. (C) Untargeted metabolomics measuring the ratio of aKG/D-2HG in murine BMDCs following 16-h exposure to LPS or <italic toggle="yes">Alternaria</italic>.</p></caption><graphic xlink:href="nihms-1945919-f0001" position="float"/></fig><fig position="float" id="F2"><label>FIGURE 2</label><caption><p id="P14">D-2HG reduces allergic sensitization to <italic toggle="yes">Alternaria</italic> in vivo. Mice were treated with octyl-D2HG prior to exposure to <italic toggle="yes">Alternaria</italic>. (A) Representative flow cytometry plots of Th2 cells (pre-gated on CD4<sup>+</sup>, TCR&#x003b2;<sup>+</sup>, CD44<sup>+</sup>, B220<sup>&#x02212;</sup>, CXCR5<sup>&#x02212;</sup>) in the mLNs of mice 8 days after intranasal <italic toggle="yes">Alternaria</italic> sensitization. (B) Quantification of Th2 cells. (C) Representative flow cytometry plots of Tfh13 cells (pre-gated on CD4<sup>+</sup>, TCR&#x003b2;<sup>+</sup>, CD44<sup>+</sup>, B220<sup>&#x02212;</sup>, CXCR5<sup>+</sup>, PD-1<sup>+</sup>), (D) Tfh13 cells quantification. (E) IgE<sup>+</sup> GCBCs (B220<sup>+</sup>, CD138<sup>&#x02212;</sup>, CD95<sup>+</sup>, GL-7<sup>+</sup>, IgE<sup>+</sup>) and (F) IgE<sup>+</sup> PCs (B220<sup>+</sup>, CD138<sup>+</sup>, IgE<sup>+</sup>), and (G) Tfr cells. (H) Schematic diagram of asthma model and mouse treatments. (I) Analysis of airway hyperreactivity on Day 31. (J) Bronchoalveolar lavage fluid (BALF) levels of antigen-specific IgE and (K) MCPT-1. <italic toggle="yes">N</italic> = 6&#x02013;8 per group. *<italic toggle="yes">p</italic> &#x0003c; .05, **<italic toggle="yes">p</italic> &#x0003c; .01 by Kruskal&#x02013;Wallis test and Dunn&#x02019;s multiple comparisons test.</p></caption><graphic xlink:href="nihms-1945919-f0002" position="float"/></fig></floats-group></article>
